Additionally, three patients presented with calcification in their CCM, with two experiencing symptomatic intracranial hemorrhage.<h4>Conclusion</h4>The observed incidence of symptomatic intracranial hemorrhage following intravenous tissue plasminogen activator administration appears to be elevated in patients with CCM. This evidence concerns the gene PLAT and cerebral cavernous malformation.